4.7 Article

Automethylation of PRC2 promotes H3K27 methylation and is impaired in H3K27M pediatric glioma

期刊

GENES & DEVELOPMENT
卷 33, 期 19-20, 页码 1428-1440

出版社

COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
DOI: 10.1101/gad.328773.119

关键词

automethylation; H3K27M; PRC2; pediatric glioma; Polycomb

资金

  1. New York University School of Medicine
  2. Laura and Isaac Perlmutter Cancer Center support grant, National Cancer Institute [P30CA016087]
  3. National Institutes of Health (NIH) [R01CA199652]
  4. Howard Hughes Medical Institute (HHMI)
  5. Making Headway Foundation St. Baldrick's Research Grant [189290]
  6. American Cancer Society [PF-17-035-01]
  7. Vilcek Scholarship
  8. NIH [K99AA024837, R01GM110174, P01CA196539]
  9. NATIONAL CANCER INSTITUTE [P01CA196539] Funding Source: NIH RePORTER

向作者/读者索取更多资源

The histone methyltransferase activity of PRC2 is central to the formation of H3K27me3-decorated facultative heterochromatin and gene silencing. In addition, PRC2 has been shown to automethylate its core subunits, EZH1/EZH2 and SUZ12. Here, we identify the lysine residues at which EZH1/EZH2 are automethylated with EZH2-K510 and EZH2-K514 being the major such sites in vivo. Automethylated EZH2/PRC2 exhibits a higher level of histone methyltransferase activity and is required for attaining proper cellular levels of H3K27me3. While occurring independently of PRC2 recruitment to chromatin, automethylation promotes PRC2 accessibility to the histone H3 tail. Intriguingly, EZH2 automethylation is significantly reduced in diffuse intrinsic pontine glioma (DIPG) cells that carry a lysine-to-methionine substitution in histone H3 (H3K27M), but not in cells that carry either EZH2 or EED mutants that abrogate PRC2 allosteric activation, indicating that H3K27M impairs the intrinsic activity of PRC2. Our study demonstrates a PRC2 self-regulatory mechanism through its EZH1/2-mediated automethylation activity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Biology

Evolution, developmental expression and function of odorant receptors in insects

Hua Yan, Shadi Jafari, Gregory Pask, Xiaofan Zhou, Danny Reinberg, Claude Desplan

JOURNAL OF EXPERIMENTAL BIOLOGY (2020)

Article Clinical Neurology

Phosphorylated tau interactome in the human Alzheimer's disease brain

Eleanor Drummond, Geoffrey Pires, Claire MacMurray, Manor Askenazi, Shruti Nayak, Marie Bourdon, Jiri Safar, Beatrix Ueberheide, Thomas Wisniewski

Article Biochemistry & Molecular Biology

Thermus thermophilus Argonaute Functions in the Completion of DNA Replication

Samson M. Jolly, Ildar Gainetdinov, Karina Jouravleva, Han Zhang, Lara Strittmatter, Shannon M. Bailey, Gregory M. Hendricks, Avantika Dhabaria, Beatrix Ueberheide, Phillip D. Zamore

Article Biology

Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion

Russell J. Ledet, Sophie E. Ruff, Yu Wang, Shruti Nayak, Jeffrey A. Schneider, Beatrix Ueberheide, Susan K. Logan, Michael J. Garabedian

Summary: Through a chemical genetics screen and phospho-proteomics, Ledet and Ruff et al identify substrates of the oncogenic kinase PIM1 in prostate cancer cells. They find that NDRG1 protein is destabilized by PIM1-mediated phosphorylation to reduce its metastasis suppressor function. These findings shed light on the role of PIM1 in prostate cancer.

COMMUNICATIONS BIOLOGY (2021)

Article Cell Biology

SHP2 Targets ITK Downstream of PD-1 to Inhibit T Cell Function

Marianne Strazza, Kieran Adam, Shalom Lerrer, Johanna Straube, Sabina Sandigursky, Beatrix Ueberheide, Adam Mor

Summary: PD-1 is a critical therapeutic target in cancer immunotherapy, with SHP2 playing a key role in its downstream signaling. Research has found that SHP2 specifically dephosphorylates ITK, which is associated with PD-1 inhibitory cellular functions. ITK may be a unique target in this pathway, and combining ITK inhibitors with PD-1 blockade may improve cancer treatment outcomes.

INFLAMMATION (2021)

Article Oncology

Mitochondrial STAT3 regulates antioxidant gene expression through complex I-derived NAD in triple negative breast cancer

Tanaya Lahiri, Lara Brambilla, Joshua Andrade, Manor Askenazi, Beatrix Ueberheide, David E. Levy

Summary: Mitochondrial STAT3 regulates complex I dehydrogenase activity, impacting NAD+ regeneration, thus indirectly controlling antioxidant gene expression to promote proliferation and migration in triple-negative breast cancer cells.

MOLECULAR ONCOLOGY (2021)

Article Multidisciplinary Sciences

Structures of monomeric and dimeric PRC2:EZH1 reveal flexible modules involved in chromatin compaction

Daniel Grau, Yixiao Zhang, Chul-Hwan Lee, Marco Valencia-Sanchez, Jenny Zhang, Miao Wang, Marlene Holder, Vladimir Svetlov, Dongyan Tan, Evgeny Nudler, Danny Reinberg, Thomas Walz, Karim-Jean Armache

Summary: Polycomb Repressive Complex 2 (PRC2) regulates gene silencing through the selective incorporation of catalytic subunits EZH1 or EZH2, with the EZH1-containing PRC2 dimer showing significant conformational changes when bound to a nucleosome.

NATURE COMMUNICATIONS (2021)

Article Clinical Neurology

Proteomics and Transcriptomics of the Hippocampus and Cortex in SUDEP and High-Risk SUDEP Patients

Dominique F. Leitner, James D. Mills, Geoffrey Pires, Arline Faustin, Eleanor Drummond, Evgeny Kanshin, Shruti Nayak, Manor Askenazi, Chloe Verducci, Bei Jun Chen, Michael Janitz, Jasper J. Anink, Johannes C. Baayen, Sander Idema, Erwin A. van Vliet, Sasha Devore, Daniel Friedman, Beate Diehl, Catherine Scott, Roland Thijs, Thomas Wisniewski, Beatrix Ueberheide, Maria Thom, Eleonora Aronica, Orrin Devinsky

Summary: The proteomic and transcriptomic analyses showed no differences between SUDEP patients and non-SUDEP epilepsy patients in hippocampus and cortex, suggesting diverse epilepsy syndromes and comorbid conditions in SUDEP. Further studies with larger cohorts and different epilepsy syndromes may reveal the molecular mechanisms underlying SUDEP.

NEUROLOGY (2021)

Article Multidisciplinary Sciences

ORF10?Cullin-2?ZYG11B complex is not required for SARS-CoV-2 infection

Elijah L. Mena, Callie J. Donahue, Laura Pontano Vaites, Jie Li, Gergely Rona, Colin O'Leary, Luca Lignitto, Bearach Miwatani-Minter, Joao A. Paulo, Avantika Dhabaria, Beatrix Ueberheide, Steven P. Gygi, Michele Pagano, J. Wade Harper, Robert A. Davey, Stephen J. Elledge

Summary: The study found an interaction between ORF10 and CRL2ZYG11B but no evidence that ORF10 is functioning to inhibit or hijack CRL2ZYG11B.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Article Cardiac & Cardiovascular Systems

Global identification of S-palmitoylated proteins and detection of palmitoylating (DHHC) enzymes in heart

Madeleine R. Miles, John Seo, Min Jiang, Zachary T. Wilson, Janay Little, Jon Hao, Joshua Andrade, Beatrix Ueberheide, Gea-Ny Tseng

Summary: High-throughput experiments suggest that around 20% of human proteins may undergo S-palmitoylation, with proteins in the cardiac palmitoylome mainly involved in cell-cell junctions and mitochondrial enzyme organization. The cardiac palmitoylome is uniquely enriched in proteins related to the organization of t-tubules, costameres, and intercalated discs.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)

Article Medicine, Research & Experimental

Proteomic Characterization of Senescent Laryngeal Adductor and Plantaris Hindlimb Muscles

Adrianna C. Shembel, Evgeny Kanshin, Beatrix Ueberheide, Aaron M. Johnson

Summary: This study compared global protein expression in laryngeal and hindlimb muscles, finding over 1,000 proteins in common across age groups. Age-related differences were observed in 107 proteins in hindlimb muscle and 19 proteins in laryngeal muscle. Differences in protein expression may relate to immune responses, stress redox, and RNA repair.

LARYNGOSCOPE (2022)

Article Multidisciplinary Sciences

A predictive model for vertebrate bone identification from collagen using proteomic mass spectrometry

Heyi Yang, Erin R. Butler, Samantha A. Monier, Jennifer Teubl, David Fenyo, Beatrix Ueberheide, Donald Siegel

Summary: Proteogenomics is a method for species identification by analyzing the proteome of an unknown organism, even when it is partially degraded. The identification is based on detecting species-specific peptides, which can be challenging due to current limitations in mass spectrometry and algorithm interpretation errors.

SCIENTIFIC REPORTS (2021)

Article Multidisciplinary Sciences

The H3K36me2 writer-reader dependency in H3K27M-DIPG

Jia-Ray Yu, Gary LeRoy, Devin Bready, Joshua D. Frenster, Ricardo Saldana-Meyer, Ying Jin, Nicolas Descostes, James M. Stafford, Dimitris G. Placantonakis, Danny Reinberg

Summary: The study identified that H3K36me2 promotes tumorigenesis in H3K27M-DIPG by affecting the writing activity of NSD1 and NSD2, as well as the reading factors LEDGF and HDGF2. Loss of NSD1/2 impedes cellular proliferation and tumorigenesis.

SCIENCE ADVANCES (2021)

Review Biochemistry & Molecular Biology

The role of EZH1 and EZH2 in development and cancer

Soo Hyun Lee, Yingying Li, Hanbyeol Kim, Seounghyun Eum, Kyumin Park, Chul-Hwan Lee

Summary: PRC2/EZH1 and PRC2/EZH2 have distinct functions in early and late developmental stages, and their dysregulation is associated with cancer and developmental diseases. Understanding the differences in their expression patterns, histone methyltransferase activity, and DNA/nucleosome binding activity can provide insights into their roles in heterochromatin formation.

BMB REPORTS (2022)

Article Clinical Neurology

Proteomic differences in the hippocampus and cortex of epilepsy brain tissue

Geoffrey Pires, Dominique Leitner, Eleanor Drummond, Evgeny Kanshin, Shruti Nayak, Manor Askenazi, Arline Faustin, Daniel Friedman, Ludovic Debure, Beatrix Ueberheide, Thomas Wisniewski, Orrin Devinsky

Summary: Epilepsy is a common neurological disorder affecting over 70 million people worldwide and often characterized by high pharmaco-resistance and diverse comorbidities. Proteomic analysis revealed significant protein expression differences in epilepsy cases compared to controls, with G-protein subunit beta 1 (GNB1) showing consistent decrease across brain regions, emphasizing its potential role in epilepsy pathogenesis and suggesting novel therapeutic strategies.

BRAIN COMMUNICATIONS (2021)

暂无数据